Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12252480 | Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide | Philip Jones, Michael Soth, Kang Le, Gang Liu | 2025-03-18 |
| 12172992 | Pyrimidines for degrading Bruton's tyrosine kinase | Zhiguo Bian, Zhaozhong J. Jia, Xingyu Jiang, Matthew H. Katcher, Venkat Reddy Mali +7 more | 2024-12-24 |
| 11958849 | GLS1 inhibitors for treating disease | Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew Hamilton, Zhijun Kang +11 more | 2024-04-16 |
| 11932643 | Substituted heterocyclic inhibitors of PTPN11 | Philip Jones, Jason CROSS, Timothy McAfoos, Zhijun Kang | 2024-03-19 |
| 11713313 | GLS1 inhibitors for treating disease | Richard T. Lewis, Philip Jones, Alessia Petrocchi, Naphtali Reyna, Matthew Hamilton +3 more | 2023-08-01 |
| 11603365 | Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide | Philip Jones, Michael Soth, Kang Le, Gang Liu | 2023-03-14 |
| 11370786 | GLS1 inhibitors for treating disease | Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew Hamilton, Zhijun Kang +11 more | 2022-06-28 |
| 10954193 | Substituted indole Mcl-1 inhibitors | Taekyu Lee, Kwangho Kim, Plamen P. Christov, Johannes Belmar, Edward T. Olejniczak +1 more | 2021-03-23 |
| 10954243 | Substituted heterocyclic inhibitors of PTPN11 | Philip Jones, Jason CROSS, Timothy McAfoos, Zhijun Kang | 2021-03-23 |
| 10899740 | Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide | Philip Jones, Michael Soth, Kang Le, Gang Liu | 2021-01-26 |
| 10766892 | GLS1 inhibitors for treating disease | Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew Hamilton, Zhijun Kang +11 more | 2020-09-08 |
| 10738043 | GLS1 inhibitors for treating disease | Richard T. Lewis, Philip Jones, Alessia Petrocchi, Naphtali Reyna, Matthew Hamilton +3 more | 2020-08-11 |
| 10344025 | GLS1 inhibitors for treating disease | Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew Hamilton, Zhijun Kang +11 more | 2019-07-09 |
| 10150753 | Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyrdin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide | Philip Jones, Michael Soth, Kang Le, Gang Liu | 2018-12-11 |
| 10125128 | GLS1 inhibitors for treating disease | Richard T. Lewis, Philip Jones, Alessia Petrocchi, Naphtali Reyna, Matthew Hamilton +3 more | 2018-11-13 |
| 10005728 | Substituted indole Mcl-1 inhibitors | Taekyu Lee, Kwangho Kim, Plamen P. Christov, Johannes Belmar, Edward T. Olejniczak +1 more | 2018-06-26 |
| 9949965 | Tricyclic indole Mcl-1 inhibitors and uses thereof | Taekyu Lee, Edward T. Olejniczak, Johannes Belmar, Zhiguo Bian, Stephen W. Fesik | 2018-04-24 |
| 9809588 | GLS1 inhibitors for treating disease | Maria Emilia Di Francesco, Philip Jones, Timothy Heffernan, Matthew Hamilton, Zhijun Kang +11 more | 2017-11-07 |
| 9573977 | Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation | Seth Rubin | 2017-02-21 |
| 9365621 | Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation | Seth Rubin | 2016-06-14 |
| 8552186 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors | Gulzar Ahmed, Henry J. Breslin, Matthew A. Curry, James L. Diebold, Bruce D. Dorsey +16 more | 2013-10-08 |
| 8148391 | Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-Met inhibitors | Gulzar Ahmed, Henry J. Breslin, Matthew A. Curry, James L. Diebold, Bruce D. Dorsey +16 more | 2012-04-03 |